¬‰Ê”­•\i‘S‘́j¬‰Ê”­•\i‘S‘́j

Šw‰ï”­•\i‘S‘́j

2020

  1. SARS-CoV-2 SˆË‘¶“I‚ȍזE—Z‡ƒAƒbƒZƒC‚É‚æ‚éRŒŒ‰t‹ÃŒÅÜƒiƒtƒ@ƒ‚ƒXƒ^ƒbƒg‚̍RƒEƒCƒ‹ƒXŠ´õì—p‚Ì”­Œ©@The anticoagulant Nafamostat potently inhibits SARS-CoV-2 S protein-mediated fusion in a cell fusion assay system and viral infection in vitro in a cell-type-dependent manner. Mizuki Yamamoto, Jun-ichiro Inoue, Yasushi Kawaguchi, Jin Gohda. ‘æ43‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ï, 2020/12/3, (Poster).
  2. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŠ´õ‚Ì•ªŽq‹@\. ìŒû”J. ‘æ50‰ñ“ú–{”畆–ƉuƒAƒŒƒ‹ƒM[Šw‰ï‘‰ïŠwp‘å‰ï, ‚’mŽs•¶‰»ƒvƒ‰ƒU‚©‚é‚ہ[‚Æ, ‚’mŒ§‚’mŽs, 2020/12/22-24, (Oral).
  3. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚Ì•aŒ´«”­Œ»‹@\. ìŒû”J. ‘æ3‰ñHZESƒtƒH[ƒ‰ƒ€, TKPƒK[ƒfƒ“ƒVƒeƒB•iì, “Œ‹ž“s`‹æ, 2020/2/16, (Oral).
  4. ƒEƒCƒ‹ƒXŒ¤‹†‚ŐV‚µ‚¢ƒTƒCƒGƒ“ƒX‚ðØ‚è‘ñ‚­. ìŒû”J. –kŠC“¹‘åŠw‘n–ò‰ÈŠwŒ¤‹†‹³ˆçƒZƒ“ƒ^[E“ú–{¶•¨•¨—Šw‰ï–kŠC“¹Žx•”u‰‰‰ï, –kŠC“¹‘åŠw, –kŠC“¹ŽD–yŽs, 2020/1/27, (Oral).

2019

  1. Insertional mutagenesis of the distal C-terminal heptad repeat (CHR) of the HIV-1 gp41 subunit. Hongyun Wang, Jiping Song, Yasushi Kawaguchi, Jun-ichiro Inoue, Zene Matsud, ‘æ‚R‚R‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ï, ŒF–{Œ§ŒF–{Žs, 2019/11/27-29, (Poster).
  2. Analysis of the insertion mutants in the distal ƒ¿9 portion of C-terminal heptad repeat (CHR) of the HIV-1 gp41 subunit. Hongyun Wang, Jiping Song, Yasushi Kawaguchi, Jun-ichiro Inoue, Zene Matsuda. Asian-African Research Forum on Emerging and Reemerging Infections 2019, –kŠC“¹‘åŠw, –kŠC“¹ŽD–yŽs, 2019/9/5-6,(Poster).
  3. Contribution of electrostatic attraction to the self-association of split reporter proteins for membrane fusion. Jiping Song, Hongyun Wang, Yasushi Kawaguchi, Jun-ichiro Inoue, Zene Matsuda. Asian-African Research Forum on Emerging and Reemerging Infections 2019, –kŠC“¹‘åŠw, –kŠC“¹ŽD–yŽs, 2019/9/5-6,(Poster).
  4. Analysis of the insertion mutants in the distal ƒ¿9 portion of C-terminal heptad repeat (CHR) of the HIV-1 gp41 subunit. Hongyun Wang, Qingling Du, Jiping Song, Yasushi Kawaguchi, Jun-ichiro Inoue, Zene Matsuda. Retroviruses, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA, 2019/5/20-25,@(Poster).
  5. Molecular mechanisms of herpes simplex virus replication and pathogenicity. Yasushi Kawaguchi. International Joint Forum on Infectious Disease Research 2019, ’†‘‰ÈŠw‰@”÷¶•¨Œ¤‹†Š, –k‹žŽs, ’†‘, 2019/12/17, (Oral).
  6. Novel evasion mechanisms against innate and adaptive immune responses by herpes simplex virus. Yasushi Kawaguchi. ‘æ48‰ñ“ú–{–ƉuŠw‰ïŠwpW‰ï, ƒAƒNƒgƒVƒeƒB•l¼, Ã‰ªŒ§•l¼Žs, 2019/12/11-13, (Oral).
  7. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚Ì‘BE•a‘Ô”­Œ»‹@\. ìŒû”J. “¡“cˆã‰È‘åŠw‘åŠw‰@ˆãŠwŒ¤‹†‰È ˆãŠwƒZƒ~ƒi[, “¡“cˆã‰È‘åŠw, ˆ¤’mŒ§–L–¾Žs, 2019/11/22, (Oral).
  8. The role of Us3 mediated UL7 phosphorylation during the evolution of ƒ¿-herpesviruses. Misato Shibazaki, Akihisa Kato, Jumpei Ito, Mai Suganami, Kosuke Takeshima, Yuhei Maruzuru, Naoto Koyanagi, Jun Arii, Kei Sato, Yasushi Kawaguchi. ‘æ67‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ƒ^ƒ[ƒz[ƒ‹‘D–x, “Œ‹ž“s]ŒËì‹æ, 2019/10/29-31,(Oral).
  9. The roles of glycerophospholipids in HSV-1 replication. Jun Arii, Ayano Fukui, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. ‘æ67‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ƒ^ƒ[ƒz[ƒ‹‘D–x, “Œ‹ž“s]ŒËì‹æ, 2019/10/29-31, (Oral).
  10. Regulatory mechanism of the substrate specificity of Us3 protein kinase encoded by herpes simplex virus-1. Akihisa Kato, Nami Kimura, Naoto Koyanagi, Yuhei Maruzuru, Jun Arii, Manabu Igarashi, Yasushi Kawaguchi. ‘æ67‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ƒ^ƒ[ƒz[ƒ‹‘D–x, “Œ‹ž“s]ŒËì‹æ, 2019/10/29-31,(Oral).
  11. Identification of the Capsid Binding Site in the Herpes Simplex Virus 1 Nuclear Egress Complex and Its Role in Viral Primary Envelopment and Replication. Kosuke Takeshima, Jun Arii, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. ‘æ67‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ƒ^ƒ[ƒz[ƒ‹‘D–x, “Œ‹ž“s]ŒËì‹æ, 2019/10/29-31,(Oral).
  12. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚Ì‘BE•aŒ´«”­Œ»‹@\. ìŒû”J. ‹{è‘åŠw‘åŠw‰@“Á•ÊƒZƒ~ƒi[, ‹{è‘åŠw, ‹{èŒ§‹{èŽs, 2019/10/11,(Oral).
  13. J-GRID project in the University of Tokyo: China-Japan Research Collaboration on Defense against Emerging and Reemerging Infections. Yasushi Kawaguchi. Asian-African Research Forum on Emerging and Reemerging Infections 2019, –kŠC“¹‘åŠw, –kŠC“¹ŽD–yŽs, 2019/9/5-6,(Oral).
  14. J-GRID project in the University of Tokyo: China-Japan Research Collaboration on Defense against Emerging and Reemerging Infections. Mitsue Hayashi and Yasushi Kawaguchi. Asian-African Research Forum on Emerging and Reemerging Infections 2019, –kŠC“¹‘åŠw, –kŠC“¹ŽD–yŽs, 2019/9/5-6,(Poster).
  15. Regulation of herpes simplex virus-2 UL13 protein kinase by phosphorylation is important for viral replication, pathogenic manifestations, and virulence in vivo. Naoto Koyanagi, Akihisa Kato, Yuhei Maruzuru, Jun Arii, and Yasushi Kawaguchi.Asian-African Research Forum on Emerging and Reemerging Infections 2019, –kŠC“¹‘åŠw, –kŠC“¹ŽD–yŽs, 2019/9/5-6,(Poster).
  16. Molecular mechanisms of herpes simplex virus replication and pathogenesis. Yasushi Kawaguchi. ‘æ18‰ñ‚ ‚킶Š´õ‚ƖƉu‘ÛƒtƒH[ƒ‰ƒ€, ’W˜H–²•‘‘䍑Û‰ï‹cê, •ºŒÉŒ§’W˜HŽs, 2019/9/10-13,(Oral).
  17. Evolutionary analysis of UL7 phosphorylation events encoded byƒ¿-herpesviruses. Misato Shibazaki, Akihisa Kato, Jumpei Ito, Mai Suganami, Kosuke Takeshima, Yuhei Maruzuru, Naoto Koyanagi, Jun Arii, Kei Sato, and Yasushi Kawaguchi. ‘æ18‰ñ‚ ‚킶Š´õ‚ƖƉu‘ÛƒtƒH[ƒ‰ƒ€, ’W˜H–²•‘‘䍑Û‰ï‹cê, •ºŒÉŒ§’W˜HŽs, 2019/9/10-13,(Oral & Poster).
  18. Identification of a cellular protein that interacts with the HSV-1 UL31/UL34 complex and regulates HSV-1 de-envelopment. Fumio Maeda, Jun Arii, Misato Shibazaki, Keiko Shindo, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato and Yasushi Kawaguchi. ‘æ18‰ñ‚ ‚킶Š´õ‚ƖƉu‘ÛƒtƒH[ƒ‰ƒ€, ’W˜H–²•‘‘䍑Û‰ï‹cê, •ºŒÉŒ§’W˜HŽs, 2019/9/10-13,(Poster).
  19. Identification of the capsid binding site in the herpes simplex virus 1 nuclear egress complex and its role in viral primary envelopment and replication. Kosuke Takeshima, Jun Arii, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, and Yasushi Kawaguchi. ‘æ18‰ñ‚ ‚킶Š´õ‚ƖƉu‘ÛƒtƒH[ƒ‰ƒ€, ’W˜H–²•‘‘䍑Û‰ï‹cê, •ºŒÉŒ§’W˜HŽs, 2019/9/10-13,(Poster).
  20. Roles of the inter-hexamer contact site for hexagonal lattice formation of herpes simplex virus 1 nuclear egress complex in viral primary envelopment and replication. Jun Arii, Kosuke Takeshima, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. ‘æ18‰ñ‚ ‚킶Š´õ‚ƖƉu‘ÛƒtƒH[ƒ‰ƒ€, ’W˜H–²•‘‘䍑Û‰ï‹cê, •ºŒÉŒ§’W˜HŽs, 2019/9/10-13,(Poster).
  21. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚Ì‘BE•a‘Ô”­Œ»‹@\. ìŒû”J. ‘æ33‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒlƒXƒgƒzƒeƒ‹“ß”e, ‰«“ꌧ“ß”eŽs, 2019/6/20-22,(Oral)
  22. UL7 ƒŠƒ“Ž_‰»§Œä‹@\‚ÌŠl“¾‚ƃ¿ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXˆŸ‰È‚̐i‰». ŽÄè”ü—¢, ‰Á“¡“N‹v, ˆÉ“Œ•½, ›”g–ƒˆß, ’|“‡Œ÷‚, ŠÛ’ß—Y•½, ¬ú咼l, —Lˆä, ²“¡‰À, ìŒû”J. ‘æ33‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒlƒXƒgƒzƒeƒ‹“ß”e, ‰«“ꌧ“ß”eŽs, 2019/6/20-22,(Oral)
  23. HSV UL13 ƒvƒƒeƒCƒ“ƒLƒi[ƒ[‚̐V‹KƒLƒi[ƒ[Šˆ«§Œä‹@\‚̉ð–¾. ¬ú咼l, ‰Á“¡“N‹v, ŠÛ’ß—Y•½, —Lˆä, ìŒû”J. ‘æ33‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒlƒXƒgƒzƒeƒ‹“ß”e, ‰«“ꌧ“ß”eŽs, 2019/6/20-22,(Oral)
  24. HSV-1 Nuclear Egress Complex ‚ƃkƒNƒŒƒIƒJƒvƒVƒh‚Æ‚ÌŒ‹‡‚́APrimary Envelopment ‚ÉŠñ—^‚·‚é. ’|“‡Œ÷‚, —Lˆä, ŠÛ’ß—Y•½, ¬–ö’¼l, ‰Á“¡“N‹v, ìŒû”J. ‘æ33‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒlƒXƒgƒzƒeƒ‹“ß”e, ‰«“ꌧ“ß”eŽs, 2019/6/20-22,(Oral)
  25. HSV-1 Us3 protein kinase‚̊“ÁˆÙ«‚ðŽi‚郊ƒ“Ž_‰»§Œä‹@\‚̉ð–¾. –Ø‘º“ì”ü, ‰Á“¡“N‹vCŒÜ\—’Šw, ŠÛ’ß—Y•½C¬ú咼lC—LˆäCìŒû”J. ‘æ33‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒlƒXƒgƒzƒeƒ‹“ß”e, ‰«“ꌧ“ß”eŽs, 2019/6/20-22,(Oral)
  26. V‹KHSV-1 ˆâ“`Žq‚Ì‹@”\‰ðÍ. ‰Á“¡“N‹vC’|“‡Œ÷‚, ŠÛ’ß—Y•½C¬ú咼lC—LˆäCìŒû”J, ‘«’BrŒá, ”ª“c’m‹v, ‰Ä–Ú“O. ‘æ33‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒlƒXƒgƒzƒeƒ‹“ß”e, ‰«“ꌧ“ß”eŽs, 2019/6/20-22,(Oral)
  27. Molecular Mechanisms of Herpes Simplex Virus Replication and Pathogenicity. Yasushi Kawaguchi. Special Seminar. University of California, Davis, Davis, USA, 2019/5/28,(Oral)
  28. Molecular Mechanisms of Herpes Simplex Virus Replication and Pathogenicity. Yasushi Kawaguchi. Harvard Medical School Special Seminar, Harvard Medical School, Boston, USA, 2019/5/21,(Oral)
  29. ƒEƒCƒ‹ƒXŒ¤‹†‚ª•R‰ð‚­‚•ªŽq•¡‡‘̂̃†ƒj[ƒN‚ÈŠjŠO—A‘—‹@\. ìŒû”J. •½¬30”N“xuŠ´õA–ƉuA‚ª‚ñA‰ŠÇvƒVƒ“ƒ|ƒWƒEƒ€, –kŠC“¹‘åŠw, –kŠC“¹ŽD–yŽs, 2019/3/27,(Oral)
  30. hŽå–Ɖu‚É‚æ‚é’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚Ì”FŽ¯‹@\‚ƃEƒCƒ‹ƒX‚É‚æ‚é–Ɖu‰ñ”ð‹@\. Sensing of herpes simplex virus by the host immunity and immune evasion by the virus. ìŒû”J. ‘æ12‰ñŽŸ¢‘ãƒAƒWƒ…ƒoƒ“ƒgŒ¤‹†‰ï, ç—¢ƒ‰ƒCƒtƒTƒCƒGƒ“ƒXƒZƒ“ƒ^[, ‘åã•{–L’†, 2019/1/22,(Oral).

2018

  1. The role of N-terminal acetylation by NatB in the shutoff activity of PA-X. Yamayoshi S. The 7th China-Japan Bilateral Symposium on All Influenza Viruses. [圳A’†‘A2018/11/2, (Oral).
  2. Characterization of a highly pathogenic avian H7N9 influenza virus. Imai M. IMSUT-CAS Workshop on Infectious Diseases 2018, “Œ‹ž, 2018/10/9, (Oral).
  3. Identification of amino acids that enhance virus replication in mammalian hosts in the PB2 and PA proteins of a highly pathogenic H7N9 influenza virus isolated from a human. Yamayoshi S, Kiso M, Yasuhara A, Ito M, Kawaoka Y. 8th Orthomyxovirus research conference, ƒnƒmƒC, ƒxƒgƒiƒ€, 2018/9/12-14, (Oral).
  4. Identification of amino acids that enhance virus replication in mammalian hosts in the PB2 and PA proteins of a highly pathogenic H7N9 influenza virus isolated from a human. Yamayoshi S, Kiso M, Yasuhara A, Ito M, Kawaoka Y. 17th Negative Strand Virus Meeting 2018, ƒxƒ[ƒi, ƒCƒ^ƒŠƒA, 2018/6/17-22, (Poster).
  5. ƒXƒyƒCƒ“‚©‚º‘å—¬s100”NA‚»‚̃Cƒ“ƒpƒNƒg‚ƃEƒCƒ‹ƒX‚̉ðÍ. ¡ˆä³Ž÷. ‘æ92‰ñ“ú–{Š´õÇŠw‰ïŠwpu‰‰‰ï@‘æ66‰ñ“ú–{‰»Šw—Ö@Šw‰ï‘‰ï‡“¯Šw‰ï@“Á•ÊŠé‰æ@ƒXƒyƒCƒ“‚©‚º‘å—¬s100Žü”N‹L”Ou‰‰, ‰ªŽR, 2018/6/1, (Oral).
  6. Human monoclonal antibodies against influenza virus. Yamayoshi S, Kawaoka Y. MEDLAB Asia Pacific & Asia Health Exhibition & Congress 2018, ƒVƒ“ƒKƒ|[ƒ‹, 2018/4/2-4, (Oral).
  7. Human monoclonal anti-HA stem neutralizing and non-neutralizing antibodies protect against influenza A virus infection. Yamayoshi S, Ito M, Uraki R, Kawaoka Y. Keystone Symposia, Antibodies as Drugs: Translating Molecules into Treatments (C1), ƒEƒBƒXƒ‰[, ƒJƒiƒ_, 2018/2/25-3/1, (Poster).
  8. ’†‘‚Å”­¶‚µ‚½‚•aŒ´«H7N9’¹ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̐³í‰ðÍ. ¡ˆä³Ž÷. 7th Negative Strand Virus-Japan, ‰«“ê, 2018/1/15-16, (Oral).
  9. ƒCƒ“ƒhƒlƒVƒA‚É‚¨‚¯‚鍂•aŒ´«H5N1’¹ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̉ðÍ. ¡‘º„˜N, ŽR“cW–í, ‰Í‰ª‹`—T. 7th Negative Strand Virus-Japan, ‰«“ê, 2018/1/15-16, (Poster).
  10. Characterization of a highly pathogenic avian H7N9 influenza virus. Imai M. 20th International Conference on Emerging Infectious Diseases in the Pacific Rim, [圳C’†‘, 2018/1/10, (Oral).
  11. Development of a quantitative split N-luc based virus-cell fusion assay of HIV-1 that allows continuous semi-real time monitoring. Mizuki Yamamoto, Qingling Du, Jiping Song, Hongyun Wang, Yasushi Kawaguchi, Jun-ichiro Inoue, Zene Matsuda.‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‹ž“sŽs‹ž“sƒeƒ‹ƒT, 2018/10/28-30,(Poster).
  12. Generation of supercharged GFP-based dual split reporter protein. Jiping Song, Yasushi Kawaguchi, Jun-ichiro Inoue, Zene Matsuda. The 32nd Annual Symposium of the Protein Society, Boston MA, USA, 2018/7/9-12, (Poster).
  13. Development of a quantitative split NanoLuc luciferase-based HIV-1 virus-cell fusion assay. Mizuki Yamamoto, Qingling Du, Jiping Song, Yasushi Kawaguchi, Jun-ichiro Inoue, Zene Matsuda. Retroviruses, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA, 2018/5/21-26, (Poster).
  14. piCode Disk–@‚ð‰ž—p‚µ‚½‚Š´“xPCR–@‚É‚æ‚éHIVƒEƒCƒ‹ƒXƒŠƒU[ƒo[’è—Ê–@‚ÌŠm—§.@—é–؈ê—Y, Î“c®b. ‘æ32‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ï,‘åã‘Û‰ï‹cê, ‘åã•{, 2018/12/2-4, (Oral).
  15. HIVö•šŠ´õ‚𐧌䂷‚éhŽåˆöŽq‚Ì“¯’肨‚æ‚щðÍ. •“àŠ°–¾, ‡“cm, Î“c®b, ²“¡Œ«•¶, Šâ£‘D, ŽR‰ª¸Ži. ‘æ32‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ï,‘åã‘Û‰ï‹cê, ‘åã•{, 2018/12/2-4, (Oral).
  16. HIVŠ´õ‚É•K—v‚ȍזEˆöŽqƒXƒNƒŠ[ƒjƒ“ƒO‚Ì‚½‚߂̃WƒtƒeƒŠƒA“Å‘f‚ÆGFP‚̃fƒBƒAƒ‹ƒXƒvƒŠƒbƒgƒ^ƒ“ƒpƒNŽ¿‚̍\’z. ‡“cm, •“àŠ°–¾, Î“c®b. ‘æ32‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ï, ‘åã‘Û‰ï‹cê, ‘åã•{, 2018/12/2-4, (Oral).
  17. HIV-1ö•šŠ´õƒvƒƒEƒCƒ‹ƒX‚̍Ċˆ«‰»‚ð—U“±‚·‚é’ᕪŽq‰»‡•¨‚Ì’Tõ. ‡“cm, —é–؈ê—Y, ˆäãƒˆê˜Y, ìŒû”J, Î“c®b. ‘æ32‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ï, ‘åã‘Û‰ï‹cê, ‘åã•{, 2018/12/2-4, (Poster).
  18. Chemical library screening for latency reverting agents to eradicate HIV-1.@Takaomi IshidaCJin GohdaCKazuo SuzukiCKai LiuCXialin XieCHiroaki TakeuchiCJun-ichiro InoueCYasushi Kawaguchi. ‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‹ž“sŽs‹ž“sƒeƒ‹ƒT, ‹ž“s•{‹ž“sŽs, 2018/10/28-30, (Oral).
  19. Sensing of herpes simplex virus by the host immunity and immune evasion by the virus. Yasushi Kawaguchi. 2018 Chonbuk National University Invited Seminar. Chonbuk National University, Iksan-si, Korea, 2018/11/7, (Oral).
  20. Sensing of herpes simplex virus by the host immunity and immune evasion by the virus. Yasushi Kawaguchi. KAI International Meeting 2018, Sejong University Convention Center, Seoul, Korea, 2018/11/7-9, (Oral).
  21. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚Ì‘BE•a‘Ô”­Œ»‹@\. ìŒû”J. ‘æ45‰ñbˆãŠw“Á•ÊƒZƒ~ƒi[, ŽRŒû‘åŠw, ŽRŒûŒ§ŽRŒûŽs, 2018/11/2, (Oral) .
  22. Molecular mechanisms of entry and egress of herpes simplex virus 1. Jun Arii.‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‹ž“sŽs‹ž“sƒeƒ‹ƒT, ‹ž“s•{‹ž“sŽs, 2018/10/28-30, (Oral).
  23. A single amino acid substitution in HSV-1 UL31 at an inter-hexamer contact site abrogates primary envelopment and viral growth. Jun Arii, Kosuke Takeshima, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. ‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‹ž“sŽs‹ž“sƒeƒ‹ƒT, ‹ž“s•{‹ž“sŽs, 2018/10/28-30, (Oral).
  24. HSV type-specific phosphorylation mediated by Us3 kinase: its role in viral pathogenesis and implication in evolution of herpesviruses. Misato Shibazaki, Akihisa Kato, Kosuke Takeshima, Naoto Koyanagi, Yuhei Maruzuru, Jun Arii, Yasushi Kawaguchi. ‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‹ž“sŽs‹ž“sƒeƒ‹ƒT, ‹ž“s•{‹ž“sŽs, 2018/10/28-30, (Oral).
  25. Residues in ƒ¿-helix 9 of HSV-1 UL31 is critical for interaction with UL25 and incorporation of capsid into vesicles in the perinuclear space. Kosuke Takeshima, Jun Arii, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. ‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‹ž“sŽs‹ž“sƒeƒ‹ƒT, ‹ž“s•{‹ž“sŽs, 2018/10/28-30, (Oral).
  26. Negative regulation of HSV-1 Us3 kinase by tyrosine phosphorylation and its role in viral replication and pathogenesis. Nami Kimura, Akihisa Kato, Yuhei Maruzuru, Naoto Koyanagi, Jun Arii, Yasushi Kawaguchi. ‘æ66‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‹ž“sŽs‹ž“sƒeƒ‹ƒT, ‹ž“s•{‹ž“sŽs, 2018/10/28-30, (Oral).
  27. Inhibition of AIM2 inflammasome activation by an HSV-1 virion component enables efficient viral replication in vivo. Yuhei Maruzuru. 25th East Asia Joint Symposium 2018, Ramada Encore Chongqing Yubei, dŒcŽs, ’†‘, 2018/10/24-27, (Poster).
  28. Sensing of herpes simplex virus by host immunity and its evasion by the virus. ìŒû”J. IMSUT-CAS Workshop on Infectious Diseases 2018. “Œ‹ž‘åŠwˆã‰ÈŠwŒ¤‹†Š,“Œ‹ž“s`‹æ, “ú–{, 2018/10/9, (Oral).
  29. A single amino acid substitution in herpes simplex virus 1 UL31 at an inter-hexamer contact site abrogates primary envelopment and viral growth. Jun Arii, Kosuke Takeshima, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. The 17th Awaji International Forum on Infection and Immunity, ’W˜H–²•‘‘䍑Û‰ï‹cê,•ºŒÉŒ§’W˜HŽs, 2018/9/4-7, (Poster).
  30. A HSV-2 specific phosphorylation event mediated by Us3 kinase is involved in viral pathogenicity in mice following vaginal infection. Misato Shibazaki, Akihisa Kato, Naoto Koyanagi, Yuhei Maruzuru, Jun Arii, Yasushi Kawaguchi. The 17th Awaji International Forum on Infection and Immunity, ’W˜H–²•‘‘䍑Û‰ï‹cê,•ºŒÉŒ§’W˜HŽs, 2018/9/4-7, (Poster).
  31. Role of amino acid residues in the ƒ¿-helix 9 of HSV-1 UL31 in its interaction with capsid proteins and nuclear egress. Kosuke Takeshima, Jun Arii, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. The 17th Awaji International Forum on Infection and Immunity, ’W˜H–²•‘‘䍑Û‰ï‹cê,•ºŒÉŒ§’W˜HŽs, 2018/9/4-7, (Poster).
  32. Novel Evasion Mechanisms against Innate and Adaptive Immune Responses by Herpes Simplex Virus.Yasushi Kawaguchi.43rd Annual International Herpesvirus Workshop, The University of British Columbia, Vancouver, Canada, 2018/7/21-25, (Oral).
  33. A single amino acid substitution in herpes simplex virus 1 UL31 at an inter-hexamer contact site abrogates primary envelopment and viral growth. Jun Arii, Kosuke Takeshima, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. 43rd Annual International Herpesvirus Workshop,The University of British Columbia, Vancouver, Canada, 2018/7/21-25, (Poster).
  34. A HSV-2 specific phosphorylation event mediated by Us3 kinase is involved in viral pathogenicity in mice following vaginal infection. Misato Shibazaki, Akihisa Kato, Naoto Koyanagi, Yuhei Maruzuru, Jun Arii, Yasushi Kawaguchi. 43rd Annual International Herpesvirus Workshop,The University of British Columbia, Vancouver, Canada, 2018/7/21-25, (Poster).
  35. Role of amino acid residues in the ƒ¿-helix 9 of HSV-1 UL31 in its interaction with capsid proteins and nuclear egress. Kosuke Takeshima, Jun Arii, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. 43rd Annual International Herpesvirus Workshop,The University of British Columbia, Vancouver, Canada, 2018/7/21-25, (Poster).
  36. HSV-1 UL-31/UL-34˜Z—Ê‘ÌŠÔŒ‹‡‚́AŠj–ŒŠÔ‚̃EƒCƒ‹ƒX—±ŽqŒ`¬‚ƃEƒCƒ‹ƒX‘B‚ɍvŒ£‚·‚é. —Lˆä, ’|“‡Œ÷‚, ŠÛ’ß—Y•½, ¬ú咼l, ‰Á“¡“N‹v, ìŒû”J. ‘æ32‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒzƒeƒ‹•Ÿ‰ªƒK[ƒfƒ“ƒpƒŒƒX, •Ÿ‰ªŒ§•Ÿ‰ªŽs, 2018/6/7-9, (Oral).
  37. Primary Envelopment‚É‚¨‚¯‚éHSV-1 UL31 ƒ¿-helix9‚Ì–ðŠ„. ’|“‡Œ÷‚, —Lˆä, ŠÛ’ß—Y•½, ¬ú咼l, ‰Á“¡“N‹v, ìŒû”J. ‘æ32‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒzƒeƒ‹•Ÿ‰ªƒK[ƒfƒ“ƒpƒŒƒX, •Ÿ‰ªŒ§•Ÿ‰ªŽs, 2018/6/7-9, (Oral).
  38. ŽÄú±”ü—¢, ‰Á“¡“N‹v, ’|“‡Œ÷‚, ŠÛ’ß—Y•½, ¬ú咼l, —Lˆä, ìŒû”J. ƒ¿ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚̐i‰»‚ÆUs3ƒŠƒ“Ž_‰»•”ˆÊ‚ÌŠl“¾. ‘æ32‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒzƒeƒ‹•Ÿ‰ªƒK[ƒfƒ“ƒpƒŒƒX, •Ÿ‰ªŒ§•Ÿ‰ªŽs, 2018/6/7-9, (Oral).
  39. V‹KHSV-1ˆâ“`Žq‚Ì“¯’è. ‰Á“¡“N‹v, ’|“‡Œ÷‚, ŠÛ’ß—Y•½, ¬ú咼l, —Lˆä, ìŒû”J, ì–ìGˆê, ‘«’BrŒá, ”ª“c’m‹v, ‰Ä–Ú“O. ‘æ32‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒzƒeƒ‹•Ÿ‰ªƒK[ƒfƒ“ƒpƒŒƒX, •Ÿ‰ªŒ§•Ÿ‰ªŽs, 2018/6/7-9, (Oral).
  40. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚̐V‚µ‚¢hŽå–Ɖu‰ñ”ð‹@\. ìŒû@”J.uŠ´õA–ƉuA‚ª‚ñA‰ŠÇvŒ¤‹†W‰ï, –kŠC“¹‘åŠwi–kŠC“¹ŽD–yŽsj, 2018/3/26, (Oral).
  41. Novel Mechanisms for Immune Evasion by Herpes Simplex virus. Yasushi Kawaguchi. International Joint Forum on Infectious Disease Research 2018, Mahidol University, ƒoƒ“ƒRƒN, ƒ^ƒC, 2018/2/27, (Oral).

2017

  1. H7N9ˆŸŒ^‚̃Cƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚̃qƒg•ª—£Š”‚ªƒ|ƒŠƒƒ‰[ƒ[’`”’Ž¿‚ÉŽ‚šM“û—Þ“K‰žƒAƒ~ƒmŽ_•ÏˆÙ‚̉ðÍ. ŽR‹g½–ç, ˆÀŒ´“Ö—m, ‘åÎN•½, –Ø‘]^‹I, ‰Í‰ª‹`—T. ‘æ160‰ñ “ú–{bˆãŠw‰ïŠwpW‰ï, Ž­Ž™“‡‘åŠw, Ž­Ž™“‡C2017/9/13-15, (Oral).
  2. Novel protective human monoclonal anti-HA stem antibodies against influenza A virus infection. Yamayoshi S, Ito M, Uraki R, Kiso M, Sasaki T, Ikuta K, Kawaoka Y. 17th International Congress of Virology, ƒVƒ“ƒKƒ|[ƒ‹, 2017/7/17-21, (Poster).
  3. A broadly reactive anti-HA stem monoclonal antibody that inhibits influenza A virus particle release. Yamayoshi S. CAS-IMSUT Workshop on Infectious Diseases, –k‹ž, ’†‘, 2017/4/13, (Oral).
  4. Development of a novel influenza rapid diagnostic kit specific for the H7 subtype. Iwatsuki-Horimoto K, Shi J, Wang X, Sakai-Tagawa Y, Ito M, Murakami K, Lopes TJS, Nakaishi K, Yamayoshi S, Watabe S, Chen H, Kawaoka Y. The 6th China]Japan Bilateral Symposium on All Influenza virus, –k‹ž, ’†‘, 2017/3/14-15, (Oral).
  5. A broadly reactive human anti-hemagglutinin stem monoclonal antibody that inhibits influenza A virus particle release. Yamayoshi S, Uraki R, Ito M, Kiso M, Nakatsu S, Yasuhara A, Oishi K, Sasaki T, Ikuta K, Kawaoka Y. The 6th China]Japan Bilateral Symposium on All Influenza virus, –k‹ž, ’†‘, 2017/3/14-15, (Oral).
  6. Cell-based membrane fusion assay for flavivirus envelope proteins. Mizuki Yamamoto, Rui Zhang, Jiping Song, Aya Watanabe, Yasushi Kawaguchi, Zene Matsuda and Jun-ichiro Inoue. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Poster).
  7. The role of the C-terminal heptad repeat (CHR) of HIV-1 gp41 in membrane fusion. Dehua Liu, Hongyun Wang, Jiping Song, Rui Zhang, Qingling Du, Yasushi Kawaguchi, Jun-ichiro Inoue and Zene Matsuda. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Poster).
  8. The screening of fragment peptides as an inhibitor of membrane fusion using the split-protein-based cell-cell fusion assay. Masanari Taniguch, Mizuki Yamamoto, Aya Watanabe, Zene Matsuda,Yasushi Kawaguchi, Jun-ichiro Inoue and Toshifumi Akizawa. The 30th Symposium on Biomedical-Analytical Sciences, Tokyo, Japan, 2017/8/28-29, (Poster).
  9. The role of the C-terminal Heptad Repeat (CHR) of HIV-1 gp41 in formation and enlargement of fusion pores. Dehua Liu, Hongyun Wang, and Zene Matsuda. The Protein Society's 31st Annual Symposium, Montreal, Canada, 2017/7/24-27, (Poster).
  10. The position dependent role of the C-terminal heptad repeat (CHR) in formation and enlargement of fusion pores. Dehua Liu, Hongyun Wang and Zene Matsuda, Retroviruses, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA, 2017/5/22-27, (Poster).
  11. HIVö•šŠ´õƒvƒƒEƒCƒ‹ƒX‚̍Ċˆ«‰»‚ð—U“±‚·‚é’ᕪŽq‰»‡•¨‚Ì’Tõ. ‡“cm, —é–؁@ˆê—Y, ˆäãƒˆê˜Y, ìŒû”JAÎ“c®b. ‘æ‚R‚P‰ñ“ú–{ƒGƒCƒYŠw‰ïŠwpW‰ï, “Œ‹ž“s’†–ì‹æ, 2017/11/24, (Poster).
  12. ESCRT-III mediates vesicle-mediated nuclear export to regulate nuclear egress of HSV-1 capsids and integrity of the inner nuclear membrane. Jun Arii, Mizuki Watanabe, Fumio Maeda, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato, Yasushi Kawaguchi. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Oral).
  13. Cell type-specific regulation of the nuclear egress of herpes simplex virus type1 by phosphorylation of UL51 Ser-184. Shinya Oda, Akihisa Kato, Yuhei Maruzuru, Naoto Koyanagi, Jun Arii, Yasushi Kawaguchi. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Oral).
  14. Evasion of AIM2-Dependent Inflamasome Activation by Herpes Simplex Virus 1 Virion Protein Enables Efficient Viral Replication In Vivo. Yuhei Maruzuru, Takeshi Ichinohe, Naoto Koyanagi, Zhuoming Liu, Tomoko Ando, Jun Arii, Akihisa Kato, Yasushi Kawaguchi. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Oral).
  15. Analysis of the magnitude of the effect of HSV-1-interacting cellular chromatin remodeling proteins on viral gene expression and replication. Yuka Sato, Yoshikazu Tanaka, Yasushi Kawaguchi. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Oral).
  16. A host cell membrane protein interacts with HSV-1 gE and promotes viral cell-to-cell spread. Mizuki Watanabe, Jun Arii, Masayuki Shimojima, Akihisa Kato, Yasushi Kawaguchi. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Oral).
  17. Function of the herpes simplex virus 2 protein kinase UL13 in vitro and in vivo is regulated by phosphorylation. Naoto Koyanagi, Akihisa Kato, Yuhei Maruzuru, Jun Arii, Yasushi Kawaguchi. ‘æ65‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ‘åãŽs‘Û‰ï‹cê, ‘åã•{‘åãŽs, 2017/10/24-26, (Oral).
  18. Yasushi Kawaguchi Novel Mechanisms for Immune Evasion by herpes simplex virus 24th East Asia Joint Symposium 2017”N10ŒŽ17“ú`2017”N10ŒŽ18“ú ”ú”iŒÎƒzƒeƒ‹i‘å’ÃŽs, “ú–{j, (Oral).
  19. Herpes Simplex Virus 1(HSV-1) UL34 Protein Regulates the Global Architecture of the Endoplasmic Reticulum in Infected Cells. Fumio Maeda. 24th East Asia Joint Symposium, ”ú”iŒÎƒzƒeƒ‹, ‘å’ÃŽs, “ú–{, 2017/10/17-18, (Oral & Poster).
  20. Virus-encoded kinases. Yasushi Kawaguchi. 9th Inhibitors of Protein Kinases Conference (IPK2017), Institute of Biochemistry and Biophysics Polish Academy of Science, ƒƒ‹ƒVƒƒƒ, ƒ|[ƒ‰ƒ“ƒh, 2017/9/17- 21, (Oral).
  21. Impact of phosphorylation of two viral proteins on the herpes simplex virus-life cycle in vitro and in vivo. Akihisa Kato, Yasushi Kawaguchi. 9th Inhibitors of Protein Kinases Conference (IPK2017), Institute of Biochemistry and Biophysics Polish Academy of Science, ƒƒ‹ƒVƒƒƒ, ƒ|[ƒ‰ƒ“ƒh, 2017/9/17- 21, (Poster).
  22. V‚µ‚¢Rƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXí—ª‚̍\’z‚ð–ÚŽw‚µ‚½í—ª“IŠî‘bŒ¤‹†. ìŒû”J. ‘æ160‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï, Ž­Ž™“‡‘åŠwŒSŒ³ƒLƒƒƒ“ƒpƒX, Ž­Ž™“‡Œ§Ž­Ž™“‡Žs, 2017/9/13-15, (Oral).
  23. ’Pƒƒwƒ‹ƒwKƒXƒEƒCƒ‹ƒXICP0‚Æ‘ŠŒÝì—p‚·‚éƒNƒƒ}ƒ`ƒ“ƒŠƒ‚ƒeJƒŠƒ“ƒNJhŽåˆöŽqŒQ‚É‚¨‚¯‚éRanBP10‚̏d—v«. ²“¡—R‰À, “c’†—ǘa, ìŒû”J. ‘æ160‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï, Ž­Ž™“‡‘åŠwŒSŒ³ƒLƒƒƒ“ƒpƒX, Ž­Ž™“‡Œ§Ž­Ž™“‡Žs, 2017/9/13-15, (Oral).
  24. ƒwƒ‹ƒwKƒXƒEƒCƒ‹ƒXƒJƒtKƒVƒgJ‚ÌŠjŠO—A‘—‚͏hŽå‹@\‚̃nƒCƒVJƒƒƒbƒN‚É‚æ‚Á‚Ä’B¬‚³‚ê‚é.—Lˆä, “n糐‹G, ìŒû”J. ‘æ160‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï, Ž­Ž™“‡‘åŠwŒSŒ³ƒLƒƒƒ“ƒpƒX, Ž­Ž™“‡Œ§Ž­Ž™“‡Žs, 2017/9/13-15, (Oral).
  25. ’Pƒƒwƒ‹ƒwKƒXƒEƒCƒ‹ƒXgE‚Æ‘ŠŒÝì—p‚µ‚čזEŠÔŠ´õ‚𑣐i‚·‚éhŽåˆöŽq‚Ì“¯’è. “n糐‹G, —Lˆä, ‰º“‡¹K, ìŒû”J. ‘æ160‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï, Ž­Ž™“‡‘åŠwŒSŒ³ƒLƒƒƒ“ƒpƒX, Ž­Ž™“‡Œ§Ž­Ž™“‡Žs, 2017/9/13-15, (Oral).
  26. Inhibition of AIM2 inflammasome activation by an HSV-1 virion component enables efficient viral replication in vivo. Yuhei Maruzuru, Takeshi Ichinohe, Naoto Koyanagi, Jun Arii, Akihisa Kato and Yasushi Kawaguchi. 42nd Annual International Herpesvirus Workshop, International Convention Center Ghent, Ghent, Belgium, 2017/7/29-8/2, (Oral).
  27. Identification of a host cell membrane protein that interacts with HSV-1 gE and promotes viral cell-to-cell spread. Mizuki Watanabe, Jun Arii, Masayuki Shimojima, Naoto Koyanagi, Yuhei Maruzuru, Akihisa Kato and Yasushi Kawaguchi. 42nd Annual International Herpesvirus Workshop, International Convention Center Ghent, Ghent, Belgium, 2017/7/29-8/2, (Oral).
  28. Herpes simplex virus type 1 UL51 protein regulates virion morphogenesis in the nucleus in a cell type and phosphorylation-dependent manner. Shinya Oda, Akihisa Kato, Naoto Koyanagi, Yuhei Maruzuru, Jun Arii and Yasushi Kawaguchi. 42nd Annual International Herpesvirus Workshop, International Convention Center Ghent, Ghent, Belgium, 2017/7/29-8/2, (Poster).
  29. ESCRT-III mediates vesicle-mediated nuclear export and regulates the integrity of the inner nuclear membrane. Jun Arii, Mizuki Watanabe, Fumio Maeda, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato and Yasushi Kawaguchi. 42nd Annual International Herpesvirus Workshop, International Convention Center Ghent, Ghent, Belgium, 2017/7/29-8/2, (Poster).
  30. Regulation of herpes simplex virus-2 UL13 protein kinase by phosphorylation is important for viral replication, pathogenic manifestations, and virulence in vivo. Naoto Koyanagi, Akihisa Kato, Yuhei Maruzuru, Jun Arii and Yasushi Kawaguchi. 42nd Annual International Herpesvirus Workshop, International Convention Center Ghent, Ghent, Belgium, 2017/7/29-8/2, (Poster).
  31. Herpes simplex 1 UL34 protein regurates the global architecture of the endoplasmic reticulum in infected cells. Fumio Maeda, Jun Arii, Yuhei Maruzuru, Naoto Koyanagi, Akihisa Kato and Yasushi Kawaguchi. 42nd Annual International Herpesvirus Workshop, International Convention Center Ghent, Ghent, Belgium, 2017/7/29-8/2, (Poster).
  32. HSV-1 UL51 ƒŠƒ“Ž_‰»§Œä‹@\‚ƍזEŽíˆË‘¶“I‚ȐV‹K‹@”\‚̉ð–¾, ”ö“c^–ç, ‰Á“¡“N‹v, ŠÛ’ß—Y•½, ¬ú咼l, —Lˆä, ìŒû”J, ‘æ31‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ¼]ƒjƒ…[ƒA[ƒoƒ“ƒzƒeƒ‹i“‡ªŒ§¼]Žsj, 2017/6/15-17, (Oral).
  33. HSV-2‚̃EƒCƒ‹ƒX‘B‚¨‚æ‚Ñ•aŒ´«‚ÍUL13ƒvƒƒeƒCƒ“ƒLƒi[ƒ[‚̃Šƒ“Ž_‰»‚É‚æ‚Á‚ЧŒä‚³‚ê‚é, ¬ú咼l, ‰Á“¡“N‹v, ŠÛ’ß—Y•½, —Lˆä, ìŒû”J, ‘æ31‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ¼]ƒjƒ…[ƒA[ƒoƒ“ƒzƒeƒ‹i“‡ªŒ§¼]Žsj, 2017/6/15-17, (Oral).
  34. ESCRT-III‚͏¬–E”}‰î«ŠjŠO—A‘—‚É‚¨‚¯‚é–ŒØ’f‚𒇉AŠj“à–Œ‚̍Pí«ˆÛŽ‚ÉŠñ—^‚·‚é, —Lˆä, “n糐‹G, ‘O“cŽj—Y, ‰Á“¡“N‹v, ìŒû”J, ‘æ31‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ¼]ƒjƒ…[ƒA[ƒoƒ“ƒzƒeƒ‹i“‡ªŒ§¼]Žsj, 2017/6/15-17, (Oral).
  35. Inhibition of AIM2 inflammasome activation by an HSV-1 virion component enables efficient viral replication in vivo. Yuhei Maruzuru, Takeshi Ichinohe, Naoto Koyanagi, Jun Arii, Akihisa Kato and Yasushi Kawaguchi, ‘æ31‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ¼]ƒjƒ…[ƒA[ƒoƒ“ƒzƒeƒ‹i“‡ªŒ§¼]Žsj, 2017/6/15-17, (Oral).
  36. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX1Œ^UL34‚͏¬–E‘Ì‚ÌŒ`‘Ԑ§Œä‚ðs‚¢AƒkƒNƒŒƒIƒJƒvƒVƒh‚ÌŠjo‰è—A‘—§ŒäˆöŽq‚ÌŠj–Œ‚ւ̏WÏ‚ÉŠÖ—^‚·‚é, ‘O“cŽj—Y, œA”¨‹g’, —Lˆä, ‰Á“¡“N‹v, ìŒû”J, ‘æ31‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ¼]ƒjƒ…[ƒA[ƒoƒ“ƒzƒeƒ‹i“‡ªŒ§¼]Žsj, 2017/6/15-17, (Oral).
  37. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX(HSV)‚̍זEŠÔŠ´õ‚𑣐i‚·‚éhŽåƒ^ƒ“ƒpƒNŽ¿‚Ì“¯’è, “n糐‹G, —Lˆä, ‰º“‡¹K, ‰Á“¡“N‹v, ìŒû”J, ‘æ31‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ¼]ƒjƒ…[ƒA[ƒoƒ“ƒzƒeƒ‹i“‡ªŒ§¼]Žsj, 2017/6/15-17, (Oral).
  38. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚ƏhŽå×–E–Œ‚Æ‚Ì‘ŠŒÝì—p, —Lˆä, ‘æ14‰ñƒEƒCƒ‹ƒXŠwƒLƒƒƒ“ƒv in “’‰ÍŒ´, ƒjƒ…[ƒEƒFƒ‹ƒVƒeƒB“’‰ÍŒ´iÃ‰ªŒ§”MŠCŽsj, 2017/6/5-6, (Oral).
  39. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXiHSVj‚̍זEŠÔ“`”d‚𑣐i‚·‚éhŽå×–E–Œƒ^ƒ“ƒpƒNŽ¿‚Ì“¯’è, “n糐‹G, —Lˆä, ‰º“‡¹K, ‰Á“¡“N‹v, ìŒû”J, ‘æ14‰ñƒEƒCƒ‹ƒXŠwƒLƒƒƒ“ƒv in “’‰ÍŒ´, ƒjƒ…[ƒEƒFƒ‹ƒVƒeƒB“’‰ÍŒ´iÃ‰ªŒ§”MŠCŽsj, 2017/6/5-6, (Oral).
  40. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚̏hŽå–Ɖu‰ñ”ð‹@\, ìŒû@”J, “ú–{¶‰»Šw‰ï–k—¤Žx•”‘æ35‰ñ‘å‰ï, ‹à‘ò‘åŠw•ó’¬ƒLƒƒƒ“ƒpƒXiÎìŒ§‹à‘òŽsj, 2017/6/3, (Oral).
  41. J Arii, Molecular mechanism of HSV-1 nuclear egress, CAS-IMSUT Workshop on Infectious Diseases Institute of Biophysics, –k‹žŽs, ’†‘, 2017/4/13, (Oral).
  42. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚̏¬–E”}‰î«ŠjŠO—A‘—‹@\, ìŒû@”J,uŠ´õA–ƉuA‚ª‚ñA‰ŠÇvŒ¤‹†W‰ï, –kŠC“¹‘åŠwˆãŠw•”ƒtƒ‰ƒeƒz[ƒ‹A’èŽRŒkƒrƒ…[ƒzƒeƒ‹i–kŠC“¹ŽD–yŽsj, 2017/3/13-14, (Oral).
  43. ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚É‚æ‚éAIM2ƒCƒ“ƒtƒ‰ƒ}ƒ\[ƒ€‰ñ”ð‹@\‚̉ð–¾, ŠÛ’ß—Y•½,uŠ´õA–ƉuA‚ª‚ñA‰ŠÇvŒ¤‹†W‰ï, –kŠC“¹‘åŠwˆãŠw•”ƒtƒ‰ƒeƒz[ƒ‹A’èŽRŒkƒrƒ…[ƒzƒeƒ‹i–kŠC“¹ŽD–yŽsj, 2017/3/13- 14, (Oral).
  44. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXUL34‚͏¬–E‘Ì‚ÌŒ`‘Ԑ§Œä‚ðs‚¢AƒkƒNƒŒƒIƒJƒvƒVƒh‚ÌŠjo‰è—A‘—§ŒäˆöŽq‚ÌŠj–Œ‚ւ̏WÏ‚ÉŠÖ—^‚·‚é, ‘O“cŽj—Y,uŠ´õA–ƉuA‚ª‚ñA‰ŠÇvŒ¤‹†W‰ï, –kŠC“¹‘åŠwˆãŠw•”ƒtƒ‰ƒeƒz[ƒ‹A’èŽRŒkƒrƒ…[ƒzƒeƒ‹i–kŠC“¹ŽD–yŽsj, 2017/3/13- 14, (Oral).

2016

  1. S. Yamayoshi, R. Uraki, M. Ito, M. Kiso, S. Nakatsu, K. Oishi, A. Yasuhara, T. Sasaki, K. Ikuta, Y. Kawaoka , A broadly reactive human anti-HA monoclonal antibody that inhibits influenza A virus particle release, Options IX for the Control of Influenza, Chicago, USA , 2016/8/24-28, (poster).
  2. A. Yasuhara, S. Yamayoshi, M. Ito, R. Uraki, S. Nakatsu, K. Oishi, P. Soni, T. Takenaga, T. Sasaki, K. Ikuta, S. Yamada, Y. Kawaoka, Characterization of the antigenic properties of influenza A(H1N1)pdm09 virus, Options IX for the Control of Influenza, Chicago, USA, 2016/8/24-28, (poster).
  3. Designing of anti-HIV-1 peptide fusion inhibitors derived from the C1 region of gp120, Wang H, Kawaguchi Y, Inoue J and Matsuda Z, Retroviruses, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA, 2016/5/23-28, (poster).
  4. Establishment of high throughput screening system for fusion inhibitors against HIV-1, Yamamoto M, Kawaguchi Y, Inoue J and Matsuda Z, Retroviruses, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA, 2016/5/23-28, (poster).
  5. Application of the dual split protein reporter to a high throughput screening of potential fusion inhibitors of HIV-1 envelope protein, Mizuki Yamamoto, Yasushi Kawaguchi, Jun-ichiro Inoue and Zene Matsuda, The 30th Protein Society Symposium, Baltimore, Maryland, USA, 2016/7/16-19, (poster).
  6. Identification of intracellular trafficking pathways of HIV-1 Env and Gag proteins by using Rab proteins, Hagiwara S, Momose F, Matsuda Z, and Morikawa Y, ‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[i–kŠC“¹ŽD–yŽsj, 2016/10/23-25, (oral).
  7. Effect of co-expression of the C1 region-derived peptide of gp120 on biosynthesis of HIV-1 envelope protein, Wang H, Kawaguchi Y, Inoue J and Matsuda Z, ‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[i–kŠC“¹ŽD–yŽsj, 2016/10/23-25, (oral).
  8. High throughput screening of fusion inhibitors for HIV-1, Matsuda Z, Yamamoto M, Kawaguchi Y, and Inoue J, ‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[i–kŠC“¹ŽD–yŽsj, 2016/10/23-25, (oral).
  9. Establishment of model cell lines for studying the transcriptional suppression of the HIV-1 genes, Liu K, Gohda J, Inoue JI, Kawaguchi Y, and Ishida T, The 15th Awaji International Forum on Infection and Immunology, Hyogo, Japan, 2016/9/6-9, (poster).
  10. Endosomal sorting protein SNX3‚ÆHSV–Œ’`”’Ž¿‚Ì‘ŠŒÝì—p‚ÉŠÖ‚·‚é‰ðÍ, ‰Á“¡“N‹v, ”d–—El, —Lˆä, ìŒû”J, ‘æ30‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒZƒ~ƒi[ƒnƒEƒX@ƒNƒƒXEƒEƒF[ƒu•{’†i“Œ‹ž“s•{’†Žsj, 2016/6/16-18, (oral).
  11. HSV-1 nuclear egress complex‚́AhŽåˆöŽq‚ð‰î‚µ‚ÄŠj“à–Œ‚̐ؒf‚ðˆø‚«‹N‚±‚·, —Lˆä, ‘O“cŽj—Y, ‰Á“¡“N‹v, ìŒû”J, 30‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒZƒ~ƒi[ƒnƒEƒX@ƒNƒƒXEƒEƒF[ƒu•{’†i“Œ‹ž“s•{’†Žsj, 2016/6/16-18, (oral).
  12. HSV-1 UL34‚É‚æ‚鏬–E”}‰î«ŠjŠO—A‘—ŠÖ˜Aƒ^ƒ“ƒpƒNŽ¿‚̋Ǎݐ§Œä, ‘O“c Žj—Y, œA”¨‹g’, ‰Á“¡“N‹v, —Lˆä, ìŒû”J, ‘æ30‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒZƒ~ƒi[ƒnƒEƒX@ƒNƒƒXEƒEƒF[ƒu•{’†i“Œ‹ž“s•{’†Žsj, 2016/6/16-18, (oral).
  13. HSV-1 UNGƒŠƒ“Ž_‰»‚̐¶•¨Šw“IˆÓ‹`, ”d–—El, ‰Á“¡“N‹v, “n糐Šó, —L ˆä, ìŒû”J, ‘æ30‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒZƒ~ƒi[ƒnƒEƒX@ƒNƒƒXEƒEƒF[ƒu•{’†i“Œ‹ž“s•{’†Žsj, 2016/6/16-18, (oral).
  14. HSV-1 ƒLƒƒƒvƒVƒhƒ^ƒ“ƒpƒNŽ¿VP26‚̓LƒƒƒvƒVƒh‚̐¬n‚𐧌䂷‚é, ¬—Ñ—º‰î, ‰Á“¡“N‹v, —Lˆä, ìŒû”J, ‘æ30‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒZƒ~ƒi[ƒnƒEƒX@ƒNƒƒXEƒEƒF[ƒu•{’†i“Œ‹ž“s•{’†Žsj, 2016/6/16-18, (oral).
  15. p53‚ÍHSV-1‚̐_Œo•aŒ´«‚ÉŠÖ—^‚·‚é, ŠÛ’ß—Y•½, ¬ú咼l, —Lˆä, ‰Á“¡ “N‹v, ìŒû”J, ‘æ30‰ñƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†‰ï, ƒZƒ~ƒi[ƒnƒEƒX@ƒNƒƒXEƒEƒF[ƒu•{’†i“Œ‹ž“s•{’†Žsj, 2016/6/16-18, (oral).
  16. Global monitoring of newly synthesized proteins induced by herpesvirus infection, using BONCAT coupled with mass spectrometry based proteomics technology, unveils novel viral coding DNA sequences, Akihisa Kato and Yasushi Kawaguchi, Nascent Chain Biology Meeting 2016iuV¶½‚̐¶•¨Šwv‘Û‰ï‹cj, •xŽmƒŒ[ƒNƒzƒeƒ‹iŽR—œŒ§“ì“s—¯ŒS•xŽm‰ÍŒûŒÎ’¬j, 2016/9/1-3, (oral).
  17. ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXnuclear egress complex‚́AhŽåˆöŽq‚ð‰î‚µ‚ÄŠj“à–Œ‚̐ؒf‚ðˆø‚«‹N‚±‚·, —Lˆä, ‘O“c•¶—Y, ‰Á“¡“N‹v, ìŒû”J, ‘æ159‰ñ“ú–{bˆãŠw‰ïŠwpW‰ï, “ú–{‘åŠw¶•¨Ž‘Œ¹‰ÈŠw•”i_“ސ쌧“¡‘òŽsj, 2016/9/6-8, (oral).
  18. ’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX‚PŒ^‚É‚æ‚鏬–E‘Ì‚ÌŒ`‘Ԑ§Œä, ‘O“cŽj—YCœA”¨‹g’C—LˆäC‰Á“¡“N‹vCìŒû”J, ‘æ13‰ñƒEƒCƒ‹ƒXŠwƒLƒƒƒ“ƒv in “’‰ÍŒ´, ƒjƒ…[ƒEƒFƒ‹ƒVƒeƒB“’‰ÍŒ´iÃ‰ªŒ§”MŠCŽsj, 2016/8/30-31, (oral and poster).
  19. Roles of Us8A and its Phosphorylation Mediated by Us3 in Herpes Simplex Virus 1 Pathogenesis, Akihisa Kato, Tomoko Ando, Jun Arii, Yasushi Kawaguchi, 41st Annual International Herpesvirus Workshop, Monona Terrace Community and Convention Center (Madison, Wisconsin, USA), 2016/7/23-27, (oral and poster).
  20. ESCRT-III mediates HSV-1 Nuclear Egress, Jun Arii, Fumio Maeda, Akihisa Kato, Yasushi Kawaguchi, 41st Annual International Herpesvirus Workshop, Monona Terrace Community and Convention Center (Madison, Wisconsin, USA), 2016/7/23-27, (oral and poster).
  21. HSV UNG phosphorylation at a specific site regulates its enzymatic activity and viral pathogenesis, Hayato Harima, Akihisa Kato, Mizuki Watanabe, Jun Arii, Yasushi Kawaguchi, ‘æ5‰ñŠ´õÇŽáŽèƒtƒH[ƒ‰ƒ€, ’W˜H–²•‘‘䍑Û‰ï‹cêi•ºŒÉŒ§’W˜HŽsj, 2016/9/4-6 , (oral and poster).
  22. HSV-1 VP26 is a Regulator of Nucleocapsid Maturation, Ryosuke Kobayashi, Akihisa Kato, Jun Arii, Yasushi Kawagushi, 41st Annual International Herpesvirus Workshop, Monona Terrace Community and Convention Center (Madison, Wisconsin, USA), 2016/7/23-27, (poster).
  23. Roles of the chaperone protein Hsp90 in herpes simplex virus 1 life cycle, Akihisa Kato, Ryo Ogawa, Mizuki Watanabe, Jun Arii, Yasushi Kawaguchi, Nascent Chain Biology Meeting 2016iuV¶½‚̐¶•¨Šwv‘Û‰ï‹cj, •xŽmƒŒ[ƒNƒzƒeƒ‹iŽR—œŒ§“ì“s—¯ŒS•xŽm‰ÍŒûŒÎ’¬j, 2016/9/1-3, (poster).
  24. Herpes simplex virus 1 VP26 is a regulator of nucleocapsid maturation, osuke Kobayashi, Akihisa Kato, Jun Arii, Yasushi Kawaguchi, The 15th Awaji International Forum on Infection and Immunityi‘æ15‰ñ‚ ‚킶‚µ‚ÜŠ´õÇE–ƉuƒtƒH[ƒ‰ƒ€j, ’W˜H–²•‘‘䍑Û‰ï‹cêi•ºŒÉŒ§’W˜HŽsj, 2016/9/6-9, (poster).
  25. Åæ’[ƒwƒ‹ƒyƒXƒEƒCƒ‹ƒXŒ¤‹†`V‚µ‚¢×–E¶•¨Šw‚ðØ‚è‘ñ‚­, ìŒû”J, Åæ’[”÷¶•¨Œ¤‹†ƒZƒ~ƒi[, ŽRŒû‘åŠwiŽRŒûŒ§ŽRŒûŽsj, 2016/10/7, (oral).
  26. Cell factors involved in a unique nuclear-pore- Potential targets for novel anti-herpetic drugs, Yasushi Kawaguchi, ‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, the 8th International Global Virus Network Meeting, ŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[i–kŠC“¹ŽD–yŽsj, 2016/10/23-25, (oral).
  27. Investigation of a novel interaction between the endosomal sorting protein SNX3 and HSV-1 membrane proteins, Akihisa Kato, ‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[i–kŠC“¹ŽD–yŽsj, 2016/10/23-25, (oral).
  28. Identification of host factors that mediate HSV-1 nuclear egress, Jun Arii, ‘æ64‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, ŽD–yƒRƒ“ƒxƒ“ƒVƒ‡ƒ“ƒZƒ“ƒ^[i–kŠC“¹ŽD–yŽsj, 2016/10/23-25, (oral).
  29. Strategies of herpesviruses to hijack host cell machinery, Yasushi Kawaguchi, Š´õÇŒ¤‹†ƒOƒ[ƒoƒ‹ƒlƒbƒgƒ[ƒNƒtƒH[ƒ‰ƒ€2016, ç—t‘åŠw•‘®•a‰@@ƒK[ƒlƒbƒgƒz[ƒ‹iç—tŒ§ç—tŽsj, 2016/11/12, (oral).

2015

  1. H7N9ƒCƒ“ƒtƒ‹ƒGƒ“ƒUƒEƒCƒ‹ƒX‚ɑ΂·‚郂ƒmƒNƒ[ƒiƒ‹R‘̂̐«ó‰ðÍ, ˆÉ“¡–r”ü, ‰Y–Ø—²‘¾, ŽR‹g½–ç, ‘ºã˜aŽj, ’†Î˜a¬, “n•”‘, ‰Í‰ª‹`—T, ‘æ63‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, •Ÿ‰ª‘Û‰ï‹cê, 2015/11/23, (poster).
  2. Identification of a novel viral protein expressed from the PB2 segment of influenza A virus, Yamayoshi S, Watanabe M, Goto H, Hatta M, Kawaoka Y, 16th Negative Strand Virus Meeting, 2015, 2015/6/16, (oral).
  3. Co-expression of HIV-1 gp120 and its C1 region-derived peptide affects biosynthesis of HIV-1 envelope protein, Wang H, Li X, Nakane S, Matsuda Z, ‘æ63‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, •Ÿ‰ª‘Û‰ï‹cê, 2015/11/22, (poster).
  4. Generation of fluorescent protein-tagged gp120 mutants to analyze the intracellular distribution of HIV-1 envelope protein, Nakane S, Matsuda Z, The 29th Annual Symposium of the Protein Society, Barcelona, Spain, 2015/7/22-25, (poster).
  5. Peptide from the C1 region of HIV-1 gp120 is a potent inhibitor of envelope protein-mediated cell-cell fusion, Wang H, Li X, Nakane S, Iwamoto A, Matsuda Z, Retroviruses (the 40th), Cold Spring Harbor Laboratory, Cold Spring Harbor, New York, USA, 2015/5/18-23, (poster).
  6. Reevaluation of coreceptor usage for the HIV-1 CRF01_AE in China, Gu L, Han Y, Yang F, Zhu T, Song X, Xie J, Gohda J, Inoue J, Kawaguchi Y, Li T, Ishida T, ‘æ63‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, •Ÿ‰ª‘Û‰ï‹cê, 2015/11/23, (poster).
  7. HIV-1 replicates in human osteoclasts and enhances their differentiation in vitro, Gohda J, The 33rd Annual Meeting of the Japanese Society for Bone and Mineral Research, Tokyo, Japan, 2015/7/23-25, (poster).
  8. Phosphorylation of an HSV-1 Us8A promotes viral pathogenicity by regulating the ability of the virus to invade the CNS from peripheral sites, Kato ACOda SCArii JCKawaguchi Y, ‘æ63‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, •Ÿ‰ª‘Û‰ï‹cê, 2015/11/23, (oral).
  9. Elucidation of the pathogenesis mechanism of herpes simplex virus type 1 Us3 protein kinasei’Pƒƒwƒ‹ƒyƒXƒEƒCƒ‹ƒX1Œ^ Us3ƒvƒƒeƒCƒ“ƒLƒi[ƒ[‚É‚æ‚é•a‘Ô”­Œ»‹@\‚̉𖾁j, Kato A, ‘æ63‰ñ“ú–{ƒEƒCƒ‹ƒXŠw‰ïŠwpW‰ï, •Ÿ‰ª‘Û‰ï‹cê, 2015/11/22, (oral).
  10. Herpes simplex virus-1 glycoproteins induce membrane deformation for efficient viral@secondary envelopment, Arii J, Kato A, Kawaguchi Y, 40th Annual International Herpesvirus Workshop, The Boise Centre, Idaho, USA , 2015/7/26, (oral).
  11. Visualization of RelB expression and activation at the single-cell level during dendritic cell maturation in Relb-Venus knock-in mice, ŠÖ’¶, ŽR–{^ŽÀ, “cŒû—S, ‹{“à^‹I, HŽRLŽq, ŽRŒûŒ›F, ‡“cm, HŽR‘אg, ˆäãƒˆê˜Y, American Association for Cancer Research, Whistler Conference Centre, British Columbia, Canada, 2016/3/13-17, (poster).
  12. ”ñŒÃ“T“INF-ƒÈBŒo˜H‚̐U“®‚Í•W“Iˆâ“`Žq‚Ì“]ŽÊ‚𐧌䂷‚é, ŠÖ’¶, “cŒû—S, HŽR‘אg, ˆäãƒˆê˜Y, ‘æ38‰ñ“ú–{•ªŽq¶•¨Šw‰ï”N‰ïE‘æ88‰ñ“ú–{¶‰»Šw‰ï‘å‰ï ‡“¯‘å‰ï, _ŒËƒ|[ƒgƒAƒCƒ‰ƒ“ƒh, 2015/12/1-4, (poster).